Geode Capital Management, LLC Greenwich Life Sciences, Inc. Transaction History
Geode Capital Management, LLC
- $1.21 Trillion
- Q3 2024
A detailed history of Geode Capital Management, LLC transactions in Greenwich Life Sciences, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 133,550 shares of GLSI stock, worth $1.63 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
133,550
Previous 127,689
4.59%
Holding current value
$1.63 Million
Previous $2.2 Million
12.89%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding GLSI
# of Institutions
38Shares Held
1.1MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY309KShares$3.77 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA274KShares$3.34 Million0.0% of portfolio
-
Credit Agricole S A87KShares$1.06 Million0.01% of portfolio
-
Northern Trust Corp Chicago, IL74.5KShares$909,6450.0% of portfolio
-
State Street Corp Boston, MA71.4KShares$871,8910.0% of portfolio
About Greenwich LifeSciences, Inc.
- Ticker GLSI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,848,200
- Market Cap $157M
- Description
- Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who ha...